Retinal Vein Occlusions Bibliography

DownloadsFellow Members Only

Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98(3):271-282. doi:10.1016/0002-9394(84)90316-7.

Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol. 1986;104(1):34-41. doi:10.1001/archopht.1986.01050130044017.

Brown DM, Campochiaro PA, Singh RP, et al; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study [published online April 9, 2010]. Ophthalmology. 2010;117(6):1124–1133. doi:10.1016/j.ophtha.2010.02.022.

Brown, DM, Heier, JS, Clark, WL, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS Study [published online December 4, 2012]. Am J Ophthalmol. 2013;155(3):429–437. doi:10.1016/j.ajo.2012.09.026.

Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study [published online June 29, 2011]. Ophthalmology. 2011;118(10):2041–2049. doi:10.1016/j.ophtha.2010.02.021.

Campochiaro PA, Clark WL, Boyer DS, et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT Study [published online October 11, 2014]. Ophthalmology. 2015;122(3):538-544. doi:10.1016/j.ophtha.2014.08.031.

Campochiaro PA, Heier JS, Feiner L, et al; BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study [published online April 15, 2010]. Ophthalmology. 2010;117(6):1102–1112. doi:10.1016/j.ophtha.2010.02.021.

Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: the Central Vein Occlusion Study Group N report. Ophthalmology. 1995;102(10):1434-1444. doi:10.1016/S0161-6420(95)30848-2.

Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115(4):486-491. doi:10.1001/archopht.1997.01100150488006.

Haller, JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion [published online April 24, 2010]. Ophthalmology. 2010;117(6):1134-1146.e3. doi:10.1016/j.ophtha.2010.03.032.

Ip MS, Scott IU, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5. Arch Ophthalmol. 2009;127(9):1101-1114. doi:10.1001/archophthalmol.2009.234.

Scott IU, Ip MS, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127(9):1115-1128. doi:10.1016/j.ophtha.2010.02.022.